Quanterix Corporation (QTRX) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

11/25

Growth 1 Margin 3 Expansion 4 Platform 1 Financial 2

latest quarter score

Earnings Reports

11
QTRX (Quanterix) Q2 2026: 23% Pro Forma Revenue Decline Spurs Commercial Overhaul
August 10, 2026
14
Quanterix (QTRX) Q1 2026: Diagnostics Revenue Jumps 81% as Alzheimer’s Bet Accelerates
June 16, 2026
13
Quanterix (QTRX) Q3 2025: $67M Synergies Realized, Integration Drives Early Cross-Sell Momentum
June 16, 2026
12
Quanterix (QTRX) Q2 2025: 29% Revenue Decline Amid Integration and Market Challenges
August 07, 2025
10
Quanterix (QTRX) Q1 2025: Akoya Deal Cut by 67% as Academic and Pharma Headwinds Deepen
July 07, 2025
20
Quanterix (QTRX) Q4 2024: 11% Revenue Growth Amid Market Headwinds and Strategic Expansion
March 17, 2025

Browse all companies